HomeKLRS • NASDAQ
add
Kalaris Therapeutics Inc
Previous close
$4.28
Day range
$3.81 - $4.18
Year range
$2.14 - $24.15
Market cap
72.75M USD
Avg Volume
472.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.26M | 192.72% |
Net income | -11.35M | -100.88% |
Net profit margin | — | — |
Earnings per share | -0.61 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 88.43M | — |
Total assets | 92.84M | — |
Total liabilities | 39.73M | — |
Total equity | 53.12M | — |
Shares outstanding | 18.70M | — |
Price to book | 1.51 | — |
Return on assets | -31.28% | — |
Return on capital | -52.38% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -11.35M | -100.88% |
Cash from operations | -12.54M | -215.76% |
Cash from investing | — | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -12.54M | -1,339.03% |
Free cash flow | -8.57M | — |
About
Founded
2019
Headquarters
Website
Employees
14
